All In MedTech

Device Trial Radar · NCT04514562

The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes: CLEAR Study

Prospective, Open-Label, Multi-Center Single-Arm Trial Designed to Assess the Safety, Performance and Efficacy of the NeVa Stent Retriever in the Treatment of Large Vessel Occlusion Strokes

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

79

Actual

Start

Apr 3, 2021

Primary completion

Dec 31, 2023

Study completion Aug 31, 2024

Sponsor

Lead sponsor
VesalioNot on our public-company list
Sponsor type
Industry
First posted
Aug 17, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, open label, single-arm 90-day study designed to assess the safety, performance and efficacy of thrombus removal in subjects presenting with acute ischemic stroke with the NeVa stent retrievers.

Conditions

  • Acute Ischemic Stroke

Interventions

  • NeVa Stent RetrieversDevice

    mechanical neurothrombectomy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Recanalization rate of the occluded target vesselTime frame: During the procedure/surgery

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Vascular Neurology of Southern California

    Thousand Oaks, California

  • Baptist Health Research Institute

    Jacksonville, Florida

  • WellStar System Inc

    Marietta, Georgia

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.